Gaurav Aggarwal
CIK 1551965 · Chief Business Officer · last filed 2025-08-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.98M
Companies
4
Total Filings
23
Lifetime Open-Market Net
$21.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNCY | Director | 1,789,915 | $7.25 | $12.98M | $0 | 7 | 2025-08-26 |
| GERN | Director | 1,970 | $1.15 | $2.3K | $0 | 4 | 2025-05-22 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $21.60M | 7 | 2022-07-01 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | 5,000 | — | — | $50.0K | 1 | 2012-08-02 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-22 | — | Grant (A) | — | $0 | |
| 2015-05-06 | — | Buy (P) | +7,500 | $27.1K | |
| 2012-08-02 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Buy (P) | +5,000 | $50.0K | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.